Minerva Neurosciences logo

Minerva Neurosciences share price today

(NERV)

Minerva Neurosciences share price is $2.16 & ₹183.55 as on 21 Dec 2024, 2.30 'hrs' IST

$2.16

0.02

(0.93%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Minerva Neurosciences share price in Dollar and Rupees. Guide to invest in Minerva Neurosciences from India. Also see the sentimental analysis on Indian investors investing in Minerva Neurosciences. Get details on the Indian mutual funds that are investing in Minerva Neurosciences. Get Analyst recommendations and forecasts along with all the Minerva Neurosciences's financials.

Minerva Neurosciences share price movements

  • Today's Low: $2.14
    Today's High: $2.23

    Day's Volatility :3.95%

  • 52 Weeks Low: $2.06
    52 Weeks High: $13.49

    52 Weeks Volatility :84.73%

Minerva Neurosciences Returns

PeriodMinerva Neurosciences, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-20.88%
-11.1%
0.0%
6 Months
-33.54%
-6.0%
0.0%
1 Year
-66.92%
2.7%
0.0%
3 Years
-72.01%
0.6%
-19.7%

Minerva Neurosciences Key Statistics

in dollars & INR

Previous Close
$2.14
Open
$2.14
Today's High
$2.228
Today's Low
$2.14
Market Capitalization
$15.0M
Today's Volume
$32.2K
52 Week High
$13.49
52 Week Low
$2.06
Revenue TTM
$0.0
EBITDA
$-24.5M
Earnings Per Share (EPS)
$-0.45
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-675.09%

How to invest in Minerva Neurosciences from India?

It is very easy for Indian residents to invest directly in Minerva Neurosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Minerva Neurosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Minerva Neurosciences or NERV on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Minerva Neurosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Minerva Neurosciences shares which would translate to 0.393 fractional shares of Minerva Neurosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Minerva Neurosciences, in just a few clicks!

Returns in Minerva Neurosciences for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Minerva Neurosciences investment value today

Current value as on today

₹1,69,118

Returns

₹69,118

(+69.12%)

Returns from Minerva Neurosciences Stock

₹66,922 (false-66.92%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Minerva Neurosciences

27%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Minerva Neurosciences on INDmoney from India has grown in the last 30 days as on Dec 22, 2024. 27% more investors are searching Minerva Neurosciences in the last 30 days versus the previous period.

Global Institutional Holdings in Minerva Neurosciences

  • Federated Hermes Inc

    19.32%

  • Vanguard Group Inc

    3.60%

  • Renaissance Technologies Corp

    2.25%

  • UBS O'Connor LLC

    1.53%

  • BlackRock Inc

    1.04%

  • Geode Capital Management, LLC

    0.81%

Analyst Recommendation on Minerva Neurosciences

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Minerva Neurosciences(by analysts ranked 0 to 5 stars)

Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
3
3
3
Sell
3
3
3

Analyst Forecast on Minerva Neurosciences

What analysts predicted

Upside of 131.48%

Current:

$2.16

Target:

$5.00

Insights on Minerva Neurosciences

  • Price Movement

    In the last 1 year, NERV stock has moved down by -67.0%
  • NERV vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 102.5%
  • NERV vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 93.6%

Minerva Neurosciences Technicals Summary

Sell

Neutral

Buy

Minerva Neurosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Minerva Neurosciences Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Minerva Neurosciences, Inc.
-3.57%
-33.54%
-66.92%
-72.01%
-96.25%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.38%
12.23%
86.41%
Biontech Se
4.48%
30.56%
7.97%
-55.71%
237.85%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.37%
26.29%
108.55%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-2.55%
77.79%
80.12%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Minerva Neurosciences, Inc.
NA
NA
0.0
-0.3
-6.75
-0.29
NA
-3.1
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Minerva Neurosciences, Inc.
Sell
$15.0M
-96.25%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
86.41%
17.51
33.61%
Biontech Se
Buy
$26.7B
237.85%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
108.55%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.12%
32.84
-4.51%

About Minerva Neurosciences

minerva neurosciences, inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of a portfolio of product candidates for the treatment of central nervous system diseases. its lead product candidate is roluperidone, which is in phase iii clinical trial, a compound for the treatment of schizophrenia. the company is also developing seltorexant that has completed phase iib clinical trial for treating insomnia and major depressive disorders; and min-301, which is in pre-clinical trial, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of parkinson's disease. minerva neurosciences, inc. has a license agreement with mitsubishi tanabe pharma corporation for the development and commercialization of the roluperidone worldwide, excluding asia; and co-development and license agreement with janssen pharmaceutica, n.v. for the development of seltorexant. the company was formerly known as cyrenaic pharmaceuticals, inc. and changed its
Organization
Minerva Neurosciences
Employees
9
CEO
Dr. Remy Luthringer Ph.D.
Industry
Health Technology

Management People of Minerva Neurosciences

NameTitle
Dr. Remy Luthringer Ph.D.
Executive Chairman & CEO
Mr. Geoffrey Robin Race F.C.M.A., M.B.A.
President
Mr. Frederick W. Ahlholm CPA
Senior VP, CFO & Secretary
Mr. Joseph Reilly
Senior VP & COO
Mr. William B. Boni
Vice President of Investor Relations & Corporate Communications
Prof. Michael Davidson M.D.
Chief Medical Officer

Important FAQs about investing in Minerva Neurosciences from India :

What is Minerva Neurosciences share price today?

Minerva Neurosciences share price today stands at $2.16, Open: $2.14 ; Previous Close: $2.14 ; High: $2.23 ; Low: $2.14 ; 52 Week High: $13.49 ; 52 Week Low: $2.06. The stock opens at $2.14, after a previous close of $2.14. The stock reached a daily high of $2.23 and a low of $2.14, with a 52-week high of $13.49 and a 52-week low of $2.06.

Can Indians buy Minerva Neurosciences shares?

Yes, Indians can invest in the Minerva Neurosciences (NERV) from India.

With INDmoney, you can buy Minerva Neurosciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Minerva Neurosciences at zero transaction cost.

How can I buy Minerva Neurosciences shares from India?

It is very easy to buy Minerva Neurosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Minerva Neurosciences be purchased?

Yes, you can buy fractional shares of Minerva Neurosciences with INDmoney app.

What are the documents required to start investing in Minerva Neurosciences stocks?

To start investing in Minerva Neurosciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Minerva Neurosciences

Today’s highest price of Minerva Neurosciences (NERV) is $2.23.

Today’s lowest price of Minerva Neurosciences (NERV) is $2.14.

What is today's market capitalisation of Minerva Neurosciences

Today's market capitalisation of Minerva Neurosciences NERV is 15.0M

What is the 52 Week High and Low Range of Minerva Neurosciences

  • 52 Week High

    $13.49

  • 52 Week Low

    $2.06

What are the historical returns of Minerva Neurosciences?

  • 1 Month Returns

    -3.57%

  • 3 Months Returns

    -33.54%

  • 1 Year Returns

    -66.92%

  • 5 Years Returns

    -96.25%

Who is the Chief Executive Officer (CEO) of Minerva Neurosciences

Dr. Remy Luthringer Ph.D. is the current Chief Executive Officer (CEO) of Minerva Neurosciences.